» Articles » PMID: 38607572

Combining T1rho and Advanced Diffusion MRI for Noninvasively Staging Liver Fibrosis: an Experimental Study in Rats

Overview
Publisher Springer
Date 2024 Apr 12
PMID 38607572
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the value of imaging parameters derived from T1 relaxation times in the rotating frame (T1ρ or T1rho), diffusion kurtosis imaging (DKI) and intravoxel incoherent motion (IVIM) in assessment of liver fibrosis in rats and propose an optimal diagnostic model based on multiparametric MRI.

Methods: Thirty rats were divided into one control group and four fibrosis experimental groups (n = 6 for each group). Liver fibrosis was induced by administering thioacetamide (TAA) for 2, 4, 6, and 8 weeks. T1ρ, mean kurtosis (MK), mean diffusivity (MD), perfusion fraction (f), true diffusion coefficient (D), and pseudo-diffusion coefficient (D*) were measured and compared among different fibrosis stages. An optimal diagnostic model was established and the diagnostic efficiency was evaluated by receiver operating characteristic (ROC) curve analysis.

Results: The mean AUC values, sensitivity, and specificity of T1ρ and MD derived from DKI across all liver fibrosis stages were comparable but much higher than those of other imaging parameters (0.954, 92.46, 91.85 for T1ρ; 0.949, 92.52, 91.24 for MD). The model combining T1ρ and MD exhibited better diagnostic performance with higher AUC values than any individual method for staging liver fibrosis (≥ F1: 1.000 (0.884-1.000); ≥ F2: 0.935 (0.782-0.992); ≥ F3: 0.982 (0.852-1.000); F4: 0.986 (0.859-1.000)).

Conclusion: Among the evaluated imaging parameters, T1ρ and MD were superior for differentiating varying liver fibrosis stages. The model combining T1ρ and MD was promising to be a credible diagnostic biomarker to detect and accurately stage liver fibrosis.

References
1.
Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

2.
Caligiuri A, Gentilini A, Pastore M, Gitto S, Marra F . Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells. 2021; 10(10). PMC: 8534788. DOI: 10.3390/cells10102759. View

3.
Shi Y, Qi Y, Lan G, Wu Q, Ma B, Zhang X . Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C. Radiology. 2021; 301(1):154-162. PMC: 8475654. DOI: 10.1148/radiol.2021202804. View

4.
Granata V, Fusco R, Belli A, Danti G, Bicci E, Cutolo C . Diffusion weighted imaging and diffusion kurtosis imaging in abdominal oncological setting: why and when. Infect Agent Cancer. 2022; 17(1):25. PMC: 9185934. DOI: 10.1186/s13027-022-00441-3. View

5.
Zhang X, Guo Q, Shi Y, Xu W, Yu S, Yang Z . Tc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn. Nucl Med Biol. 2017; 49:44-49. DOI: 10.1016/j.nucmedbio.2017.02.004. View